The Global PARP Inhibitor Market was worth USD 924 million in 2018 and is expected to expand at a CAGR of 27.4% over the forecast period. PARP is a poly (ADP-ribose) polymerase inhibitor was designed to target cancer cells withsource https://www.openpr.com/news/2285074/parp-inhibitor-market-to-exhibit-a-cagr-of-27-4-over-the-forecast